Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.838M |
Day Range | - - - |
52 Wk Range | 0.928 - 9.390 |
Market Cap | $524.370M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 4.87% |
Days to Cover | 5.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Applied Therapeutics (NASDAQ: APLT) through any online brokerage.
Other companies in Applied Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).
The latest price target for Applied Therapeutics (NASDAQ: APLT) was reported by RBC Capital on Thursday, April 11, 2024. The analyst firm set a price target for 12.00 expecting APLT to rise to within 12 months (a possible 161.44% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Applied Therapeutics (NASDAQ: APLT) is $4.59 last updated April 23, 2024 at 6:03 PM EDT.
There are no upcoming dividends for Applied Therapeutics.
Applied Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Applied Therapeutics.
Applied Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.